DOES BACKGROUND OPIOID ANALGESIA NEED A SPECIFIC OPIOID FOR BREAKTHROUGH CANCER PAIN (BTCP)? STUDY ON EFFICACY OF FENTANYL ORAVESCENT

MLA

Pota V, et al. Does Background Opioid Analgesia Need a Specific Opioid for Breakthrough Cancer Pain (Btcp)? Study on Efficacy of Fentanyl Oravescent. Jan. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3977..2f91c502dcfe3816727943054b151b1f&authtype=sso&custid=ns315887.

APA

Pota V, Sansone, P., Pace MC, Passavanti MB, Tamborino R, & Aurilio, C. (2011). Does Background Opioid Analgesia Need a Specific Opioid for Breakthrough Cancer Pain (Btcp)? Study on Efficacy of Fentanyl Oravescent.

Chicago

Pota V, Pasquale Sansone, Pace MC, Passavanti MB, Tamborino R, and Caterina Aurilio. 2011. “Does Background Opioid Analgesia Need a Specific Opioid for Breakthrough Cancer Pain (Btcp)? Study on Efficacy of Fentanyl Oravescent,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3977..2f91c502dcfe3816727943054b151b1f&authtype=sso&custid=ns315887.